| RNA Interference and Gene Delivery | Lifetime | 132 | IN 1 | 99.52 |
| Nanoparticle-Based Drug Delivery | Lifetime | 69 | IN 1 | 99.60 |
| Curcumin's Biomedical Applications | Lifetime | 16 | IN 3 | 99.07 |
| Dendrimers and Hyperbranched Polymers | Lifetime | 25 | IN 1 | 99.34 |
| Advanced biosensing and bioanalysis techniques | Lifetime | 262 | IN 2 | 99.32 |
| Nanoplatforms for cancer theranostics | Lifetime | 218 | IN 1 | 99.01 |
| Advanced Drug Delivery Systems | Lifetime | 98 | IN 15 | 98.96 |
| Graphene and Nanomaterials Applications | Lifetime | 188 | IN 9 | 98.78 |
| Advancements in Transdermal Drug Delivery | Lifetime | 150 | IN 20 | 98.03 |
| Cancer Research and Treatment | Lifetime | 24 | IN 7 | 82.45 |
| RNA Interference and Gene Delivery | 2021-2025 | 1 | IN 1 | 99.95 |
| Nanoparticle-Based Drug Delivery | 2021-2025 | 2 | IN 1 | 99.95 |
| Advanced Drug Delivery Systems | 2021-2025 | 4 | IN 1 | 99.58 |
| Advanced biosensing and bioanalysis techniques | 2021-2025 | 21 | IN 3 | 99.75 |
| Dendrimers and Hyperbranched Polymers | 2021-2025 | 1 | IN 1 | 99.86 |
| Curcumin's Biomedical Applications | 2021-2025 | 2 | IN 1 | 99.78 |
| Advancements in Transdermal Drug Delivery | 2021-2025 | 6 | IN 1 | 99.42 |
| Nanoplatforms for cancer theranostics | 2021-2025 | 33 | IN 1 | 99.72 |
| Immunotherapy and Immune Responses | 2021-2025 | 37 | IN 1 | 99.34 |
| Graphene and Nanomaterials Applications | 2021-2025 | 35 | IN 5 | 99.04 |
| Toxin Mechanisms and Immunotoxins | 2021-2025 | 12 | IN 1 | 95.58 |
| MicroRNA in disease regulation | 2021-2025 | 216 | IN 3 | 97.17 |
| Gold and Silver Nanoparticles Synthesis and Applications | 2021-2025 | 217 | IN 14 | 94.80 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 327 | IN 1 | 91.75 |
| Nail Diseases and Treatments | 2021-2025 | 109 | IN 12 | 93.49 |
| Wound Healing and Treatments | 2021-2025 | 413 | IN 9 | 92.21 |
| Lipid Membrane Structure and Behavior | 2021-2025 | 241 | IN 12 | 90.35 |
| Nanoparticles: synthesis and applications | 2021-2025 | 614 | IN 113 | 92.11 |
| Alzheimer's disease research and treatments | 2021-2025 | 977 | IN 23 | 90.49 |
| Phytochemicals and Medicinal Plants | 2021-2025 | 154 | IN 99 | 84.45 |
| Dermatology and Skin Diseases | 2021-2025 | 867 | IN 14 | 88.31 |
| Natural Antidiabetic Agents Studies | 2021-2025 | 499 | IN 72 | 85.57 |
| Bee Products Chemical Analysis | 2021-2025 | 779 | IN 20 | 81.05 |
| Cholinesterase and Neurodegenerative Diseases | 2021-2025 | 564 | IN 90 | 79.75 |
| Silk-based biomaterials and applications | 2021-2025 | 470 | IN 18 | 79.94 |
| Cancer therapeutics and mechanisms | 2021-2025 | 698 | IN 77 | 76.80 |
| Drug Solubulity and Delivery Systems | 2021-2025 | 617 | IN 80 | 79.42 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 469 | IN 12 | 71.14 |
| Inhalation and Respiratory Drug Delivery | 2021-2025 | 971 | IN 38 | 73.25 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 458 | IN 3 | 69.98 |
| Biochemical effects in animals | 2021-2025 | 803 | IN 23 | 70.81 |
| Adenosine and Purinergic Signaling | 2021-2025 | 766 | IN 15 | 65.75 |
| Pharmacological Effects of Medicinal Plants | 2021-2025 | 160 | IN 21 | 64.63 |
| Silymarin and Mushroom Poisoning | 2021-2025 | 111 | IN 10 | 62.42 |
| Berberine and alkaloids research | 2021-2025 | 339 | IN 27 | 59.56 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 704 | IN 31 | 57.11 |
| Advanced Biosensing Techniques and Applications | 2021-2025 | 963 | IN 28 | 59.36 |
| Nigella sativa pharmacological applications | 2021-2025 | 310 | IN 52 | 54.35 |
